ALI's revenues surge in second quarter of 1998
ALI's revenues surge in second quarter of 1998Canadian ultrasound miniPACS developer ALI Technologies is proving that the market for ultrasound miniPACS continues to be quite healthy. The Richmond, BC-based firm's second-quarter revenues soared
ALI's revenues surge in second quarter of 1998
Canadian ultrasound miniPACS developer ALI Technologies is proving that the market for ultrasound miniPACS continues to be quite healthy. The Richmond, BC-based firm's second-quarter revenues soared 66% compared with the same period last year.
For the quarter (end-March), revenues were $5.1 million (Canadian), compared with $3 million in 1997. Net income was $1.1 million, compared with $458,000 in 1997.
ALI installed 29 of its UltraPACS systems, including 15 departmental and 14 clinical-scale systems, during the period. The firm has also expanded its R&D space by 100%, production capacity by 200%, and service capacity by 150%.
In other ALI news, the company has grown its North American direct sales force by 50% to a total of nine people. The firm has also signed a letter of intent to acquire the assets and intellectual property of its European distributor, SeppMED. Diligence work is under way.
- Search again
- Homepage
Newsletter
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Key MRI Findings Predictive of Treatment Response for Unresectable Hepatocellular Carcinoma
July 14th 2025For patients with unresectable hepatocellular carcinoma, a pre-treatment MRI finding of LI-RADS tumor in vein was associated with over an 86 percent lower likelihood of responding to transcatheter arterial chemoembolization (TACE) and targeted immunotherapy.
